Dietary Fat and Survival After Nonmetastatic Prostate Cancer

A new cohort study published in JAMA Network provides some of the most detailed evidence to date on how the type of fat men eat after a prostate cancer diagnosis relates to long-term survival. The analysis, based on 4,884 participants in the Health Professionals Follow-Up Study followed for a median of 12.8 years, shows that higher postdiagnosis intake of saturated and animal fats is associated with greater all-cause mortality, mainly driven by deaths from cardiovascular disease and other cancers. At the same time, replacing these fats with monounsaturated and plant-based fats is associated with a meaningful reduction in overall mortality risk.

The study does not suggest that dietary fat causes prostate cancer to grow more aggressively. In fact, no clear association was found between any major fat subtype and prostate-cancer-specific mortality. Instead, the pattern points to a broader survivorship issue: men with nonmetastatic prostate cancer are more likely to die from cardiovascular disease and other cancers than from prostate cancer itself, and the composition of dietary fat appears to influence those competing risks. Men in the highest quintile of saturated fat intake had a 24% higher risk of death from any cause compared with those in the lowest quintile , and a 42% higher risk of cardiovascular death. The estimated 10-year absolute risk of death rose from 23.4% in the lowest saturated-fat quintile to 26.4% in the highest, an absolute difference of about 3 percentage points.

The most actionable finding concerns substitution. Replacing just 10% of total calories from animal fat with plant-based fat was associated with a 16% lower risk of all-cause mortality. Replacing 5% of calories from saturated fat with monounsaturated fat was associated with a 20% lower risk. Conversely, replacing 5% of calories from carbohydrates with saturated fat was associated with a 15% higher risk of death. In practical terms, this supports shifting away from butter, high-fat dairy, fatty and processed meats, and other major sources of animal and saturated fat, and toward extra-virgin olive oil, nuts, seeds, avocado, legumes, and fish. The benefit appears to come not from simply adding “healthy” fats on top of an unchanged diet, but from actively displacing less favourable fat sources within the same calorie budget.

The study has important limitations. It is observational, so it can demonstrate associations but cannot prove that changing fat intake would produce exactly the reported benefit. The cohort consisted predominantly of White male health professionals, which limits generalizability to more diverse populations. Dietary intake was estimated using food-frequency questionnaires, and postdiagnosis fat intake was based on the first eligible assessment rather than being repeatedly updated. Residual confounding from factors such as overall diet quality, physical activity, socioeconomic status, and access to care remains possible. The analysis also grouped fatty acids into broad categories rather than examining every individual fatty acid, which may have different biological effects.

Even with these caveats, the findings align with prior cohort studies in people without cancer and with earlier analyses in prostate cancer survivors, and they add substantially to the evidence base by including 12 additional years of follow-up and a threefold increase in the number of deaths compared with previous reports.

Source.